A Systematic Review of Atopic Dermatitis: The Intriguing Journey Starting from Physiopathology to Treatment, from Laboratory Bench to Bedside

被引:14
作者
Radi, Giulia [1 ]
Campanti, Anna [1 ]
Diotallevi, Federico [1 ]
Martina, Emanuela [1 ]
Marani, Andrea [1 ]
Offidani, Annamaria [1 ]
机构
[1] Polytech Marche Univ, Dermatol Clin, Dept Clin & Mol Sci, I-60126 Ancona, Italy
关键词
atopic dermatitis; pathophysiology; small molecules; biologics; novel treatments; DOUBLE-BLIND; EPIDERMAL BARRIER; BASIC SCIENCE; PLACEBO; PHASE-3; ADOLESCENTS; RECEPTORS; CYTOKINES; EFFICACY; ADULTS;
D O I
10.3390/biomedicines10112700
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Atopic dermatitis (AD) is a common chronic inflammatory and immune-mediated skin disease with a complex pathophysiology and still represents a therapeutic challenge, owing to limited responses to available treatments. However, recent advances in the understanding of AD pathophysiology have led to the discovery of several new potential therapeutic targets, and research in the field of new molecules with therapeutic perspectives is boiling, with more than 70 new promising drugs in development. The aim of this systematic review is to provide the state of the art on the current knowledge concerning the pathophysiology of the disease and on novel agents currently being investigated for AD, and to highlight which type of evolution is going to take place in therapeutic approaches of atopic dermatitis in the coming years.
引用
收藏
页数:28
相关论文
共 89 条
[11]   Topical tofacitinib for atopic dermatitis: a phase IIa randomized trial [J].
Bissonnette, R. ;
Papp, K. A. ;
Poulin, Y. ;
Gooderham, M. ;
Raman, M. ;
Mallbris, L. ;
Wang, C. ;
Purohit, V. ;
Mamolo, C. ;
Papacharalambous, J. ;
Ports, W. C. .
BRITISH JOURNAL OF DERMATOLOGY, 2016, 175 (05) :902-911
[12]   Efficacy and Safety of Upadacitinib vs Dupilumab in Adults With Moderate-to-Severe Atopic Dermatitis A Randomized Clinical Trial [J].
Blauvelt, Andrew ;
Teixeira, Henrique D. ;
Simpson, Eric L. ;
Costanzo, Antonio ;
De Bruin-Weller, Marjolein ;
Barbarot, Sebastien ;
Prajapati, Vimal H. ;
Lio, Peter ;
Hu, Xiaofei ;
Wu, Tianshuang ;
Liu, John ;
Ladizinski, Barry ;
Chu, Alvina D. ;
Eyerich, Kilian .
JAMA DERMATOLOGY, 2021, 157 (09) :1047-1055
[13]   Staphylococcus aureus and Staphylococcus epidermidis strain diversity underlying pediatric atopic dermatitis [J].
Byrd, Allyson L. ;
Deming, Clay ;
Cassidy, Sara K. B. ;
Harrison, Oliver J. ;
Ng, Weng-Ian ;
Conlan, Sean ;
Belkaid, Yasmine ;
Segre, Julia A. ;
Kong, Heidi H. .
SCIENCE TRANSLATIONAL MEDICINE, 2017, 9 (397)
[14]  
Campanati A, 2022, ARCH DERMATOL RES, V314, P593, DOI 10.1007/s00403-021-02243-w
[15]   The less-known face of dupilumab: its role in mesenchymal stem cells by interleukin-13 modulation [J].
Campanati, A. ;
Di Vincenzo, M. ;
Radi, G. ;
Rizzetto, G. ;
Carnevale, G. ;
Marchi, S. ;
Orciani, M. ;
Offidani, A. .
BRITISH JOURNAL OF DERMATOLOGY, 2021, 185 (01) :217-219
[16]   Mesenchymal Stem Cells Profile in Adult Atopic Dermatitis and Effect of IL4-IL13 Inflammatory Pathway Inhibition In Vivo: Prospective Case-Control Study [J].
Campanati, Anna ;
Orciani, Monia ;
Marani, Andrea ;
Di Vincenzo, Mariangela ;
Magi, Simona ;
Gregoriou, Stamatios ;
Diotallevi, Federico ;
Martina, Emanuela ;
Radi, Giulia ;
Offidani, Annamaria .
JOURNAL OF CLINICAL MEDICINE, 2022, 11 (16)
[17]   Janus kinase inhibitors for atopic dermatitis: a promising treatment modality [J].
Cartron, A. M. ;
Nguyen, T. H. ;
Roh, Y. S. ;
Kwatra, M. M. ;
Kwatra, S. G. .
CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2021, 46 (05) :820-824
[18]   Proof-of-concept clinical trial of etokimab shows a key role for IL-33 in atopic dermatitis pathogenesis [J].
Chen, Yi-Ling ;
Gutowska-Owsiak, Danuta ;
Hardman, Clare S. ;
Westmoreland, Melanie ;
MacKenzie, Teena ;
Cifuentes, Liliana ;
Waithe, Dominic ;
Lloyd-Lavery, Antonia ;
Marquette, Allison ;
Londei, Marco ;
Ogg, Graham .
SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (515)
[19]   The genetics of atopic dermatitis [J].
Chien, Yin-Hsiu ;
Hwu, Wuh-Liang ;
Chiang, Bor-Luen .
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2007, 33 (03) :178-190
[20]  
Chiricozzi A, 2020, IMMUNOTARGETS THER, V9, P151, DOI 10.2147/ITT.S260370